- Public Comps
- Jafco Group
Jafco Group Valuation Multiples
Discover Jafco Group's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Pantheon Infrastructure, RTW Biotech Opportunities, Clairvest Group, CBRE Clarion Glb Real Est and more.
Jafco Group Overview
About Jafco Group
Jafco Group Co Ltd is a Japan-based investment and a financial-services provider that operates under a single segment: management of funds. The company operates through its subsidiaries in the United States, Singapore, Hong Kong, and Korea. Its business involves investing in unlisted private equity companies to accomplish its objective of obtaining income and capital appreciation for its investors. The company also provides consulting services related to business management, stock listing support services, and comprehensive investment support services for business growth purposes.
Founded
1973
HQ

Employees
148
Website
Sectors
Financials (LTM)
EV
$133M
Valuation Multiples
Start free trialJafco Group Financials
Jafco Group reported last 12-month revenue of $140M and EBITDA of $38M.
In the same LTM period, Jafco Group generated $38M in EBITDA and $40M in net income.
Revenue (LTM)
Jafco Group P&L
In the most recent fiscal year, Jafco Group reported revenue of $136M and EBITDA of $51M.
Jafco Group is profitable as of last fiscal year, with gross margin of 44%, EBITDA margin of 38%, and net margin of 30%.
Financial data powered by Morningstar, Inc.
Jafco Group Stock Performance
Jafco Group has current market cap of $761M, and enterprise value of $133M.
Market Cap Evolution
Jafco Group's stock price is $14.47.
Jafco Group share price decreased by 1.2% in the last 30 days, and by 5.9% in the last year.
Jafco Group has an EPS (earnings per share) of $0.78.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $133M | $761M | -0.7% | -1.2% | 8.6% | -5.9% | $0.78 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJafco Group Valuation Multiples
Jafco Group trades at 1.0x EV/Revenue multiple, and 3.5x EV/EBITDA.
EV / Revenue (LTM)
Jafco Group Financial Valuation Multiples
As of July 14, 2026, Jafco Group has market cap of $761M and EV of $133M.
Jafco Group has a P/E ratio of 18.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jafco Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Jafco Group Margins & Growth Rates
Jafco Group grew revenue by 11% but EBITDA decreased by 16% in the last fiscal year.
In the most recent fiscal year, Jafco Group reported gross margin of 44%, EBITDA margin of 38%, and net margin of 30%.
Jafco Group Margins
Jafco Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Jafco Group Operational KPIs
Jafco Group's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.
Jafco Group's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jafco Group's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Jafco Group Competitors
Jafco Group competitors include Pantheon Infrastructure, RTW Biotech Opportunities, Clairvest Group, CBRE Clarion Glb Real Est, Pollen Street Group, Senvest Capital, Foresight Group Holdings, Beltone Holding, Syncona and Integral.
Most Jafco Group public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.8x | - | - | - | |||
| 3.1x | - | - | - | |||
| 6.0x | - | - | - | |||
| 54.3x | - | - | - | |||
| 5.3x | 5.2x | 11.4x | 11.1x | |||
| 1.9x | - | - | - | |||
| 3.0x | 3.4x | 7.2x | 7.0x | |||
| 4.0x | - | 29.9x | - | |||
This data is available for Pro users. Sign up to see all Jafco Group competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Jafco Group
Jafco Group has acquired 1 company to date.
Last acquisition by Jafco Group was on October 31st 2017. Jafco Group acquired Omicale for undisclosed valuation.
Latest Acquisitions by Jafco Group
| Description | Omicale is a Tokyo-based online platform for marriage matchmaking events in Japan. It aggregates details on over 30,000 konkatsu parties and provides matching services to more than 150,000 registered members seeking spouses. Users access event schedules, participant profiles, and counseling resources through the portal. Established in 2013, Omicale hosts virtual and in-person gatherings nationwide, partnering with event organizers and venues to facilitate connections for singles aged 20 to 50. |
| HQ Country | |
| HQ City | Tokyo |
| Deal Date | 31 Oct 2017 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Jafco Group acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by Jafco Group
Jafco Group has invested in 188 companies to date.
Latest investment by Jafco Group was on June 21st 2026. Jafco Group invested in Rege Nephro in their $8M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Jafco Group
| Description | Rege Nephro is a Tokyo-based biotechnology firm specializing in therapeutics for renal, liver, and pancreas diseases using induced pluripotent stem cell technology from Kyoto University's CiRA. It conducts R&D, production, and commercialization of cell therapies targeting organ regeneration and disease treatment. | Arrowsmith is a biotechnology company that develops bacteriophages to treat bacterial infectious diseases and address antimicrobial resistance. | DubGuild is a technology company that builds AI-powered dubbing tools for localizing video content across languages for creators and media firms. | Atom is a humanoid robot platform that combines Physical AI with bipedal dual-armed hardware. The robots function as adaptive agents for diverse work environments. | |
| HQ Country | |||||
| HQ City | Kyoto | Ibaraki | Tokyo | Tokyo | |
| Deal Date | 21 Jun 2026 | 21 Jun 2026 | 4 Jun 2026 | 26 May 2026 | |
| Round | Undisclosed stage | Series A | Seed | Seed | |
| Raised | $8M | $7M | $13M | $19M | |
| Investors | DCI Partners; JIC Venture Growth Investments; Jafco Group; Regional Healthcare Industry Revitalization Platform; Kyushin Social Capital; Chushin Venture Capital; Toho Holdings; Mitsubishi UFJ Capital; BA7 Venture Capital; Kyoto University Innovation Capital; Arcus Investment; SPARX Asset Management | ANRI; DBJ Capital; JIC Venture Growth Investments; Jafco Group | Jafco Group; Coreline Ventures; CyberAgent Capital | ANRI; JIC Venture Growth Investments; Blue Lab; Jafco Group; Sumisho Venture Partners; Beyond Next Ventures; Mitsubishi UFJ Capital; ALPHA; SMBC Venture Capital | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Jafco Group investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jafco Group
| When was Jafco Group founded? | Jafco Group was founded in 1973. |
| Where is Jafco Group headquartered? | Jafco Group is headquartered in Japan. |
| How many employees does Jafco Group have? | As of today, Jafco Group has over 148 employees. |
| Is Jafco Group publicly listed? | Yes, Jafco Group is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Jafco Group? | Jafco Group trades under 8595 ticker. |
| When did Jafco Group go public? | Jafco Group went public in 2001. |
| Who are competitors of Jafco Group? | Jafco Group main competitors include Pantheon Infrastructure, RTW Biotech Opportunities, Clairvest Group, CBRE Clarion Glb Real Est, Pollen Street Group, Senvest Capital, Foresight Group Holdings, Beltone Holding, Syncona, Integral. |
| What is the current market cap of Jafco Group? | Jafco Group's current market cap is $761M. |
| What is the current revenue of Jafco Group? | Jafco Group's last 12 months revenue is $140M. |
| What is the current revenue growth of Jafco Group? | Jafco Group revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Jafco Group? | Current revenue multiple of Jafco Group is 1.0x. |
| What is the current EBITDA of Jafco Group? | Jafco Group's last 12 months EBITDA is $38M. |
| What is Jafco Group's EBITDA margin? | Jafco Group's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Jafco Group? | Current EBITDA multiple of Jafco Group is 3.5x. |
| What is the current FCF of Jafco Group? | Jafco Group's last 12 months FCF is $64M. |
| What is Jafco Group's FCF margin? | Jafco Group's last 12 months FCF margin is 45%. |
| What is the current EV/FCF multiple of Jafco Group? | Current FCF multiple of Jafco Group is 2.1x. |
| How many companies Jafco Group has acquired to date? | As of July 2026, Jafco Group has acquired 1 company. |
| What was the largest acquisition by Jafco Group? | None of the M&A deals Jafco Group has completed have disclosed valuations. |
| What companies Jafco Group acquired? | Jafco Group acquired Omicale. |
| In how many companies Jafco Group has invested to date? | As of July 2026, Jafco Group has invested in 188 companies. |
| What was the last Jafco Group investment? | On 21st June 2026 Jafco Group invested in Rege Nephro, participating in a $8M Undisclosed stage round, alongside DCI Partners, JIC Venture Growth Investments, Regional Healthcare Industry Revitalization Platform, Kyushin Social Capital, Chushin Venture Capital, Toho Holdings, Mitsubishi UFJ Capital, BA7 Venture Capital, Kyoto University Innovation Capital, Arcus Investment, and 1 other investor. |
| In what companies Jafco Group invested in? | Jafco Group invested in Tier IV, LayerX, Synspective, Appier, Spiber, COMSA, Finatext, Huddle, Astroscale, Gumi, Kyash, Viridian Therapeutics, Baseconnect, Mirrativ, Timebank, NuvoEx, PepperTap, Thinkr, Let, Repro, and 168 other companies. |
See public comps similar to Jafco Group
Lists including Jafco Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





